Vascular Solutions

Duncan-Williams has published a research report on Vascular Solutions (NASDAQ: VASC) previewing earnings for the second quarter. In the report, Duncan-Williams wrote, "Our Q2:11 Catheters revenue estimate is $13.5 million. This represents approximately 31% growth compared to the same period last...

Wedbush is commenting on Vascular Solutions Inc.'s (NASDAQ: VASC) Q1, which it is calling a “solid quarter.” “Vascular Solutions reported Q1 results that were right on target with expectations,” Wedbush writes. “At a time when most of the medical device industry is experiencing a major downturn in...